Department of Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Biol Psychiatry. 2010 Aug 1;68(3):219-22. doi: 10.1016/j.biopsych.2010.01.028. Epub 2010 Mar 17.
Biochemical diagnostics of ethanol intake would improve alcohol abuse treatment and have applications in clinical trial and public safety settings. Self-reporting of alcohol use has clinical utility but lacks the desired reliability. Previously, proposed single-analyte biochemical tests of alcohol intake suffer from low sensitivity and specificity or examine only acute drinking and have therefore seen limited clinical use.
To address this unmet need, plasma protein biomarker discovery and validation were performed with an alcohol self-administering nonhuman primate model system to develop a diagnostic that accurately classifies subjects into nondrinking, nonabusive drinking, and abusive drinking categories.
A 17-plasma protein panel was determined that correctly classifies abusive drinking with 100% sensitivity and also differentiates any level of drinking from alcohol abstinence with 88% accuracy.
The biomarker panel reflects changes in multiple organ systems and suggests robust changes in the plasma proteome with drinking that might serve as a sensitive and specific diagnostic test. The specific plasma proteins altered with alcohol self-administration might represent indicators of alcohol-induced stress on a variety of organ systems.
乙醇摄入的生化诊断将改善酒精滥用的治疗,并在临床试验和公共安全环境中有应用。酒精使用的自我报告具有临床实用性,但缺乏所需的可靠性。以前,提出的单一分析物生化测试酒精摄入的灵敏度和特异性较低,或者仅检查急性饮酒,因此在临床上的应用有限。
为了解决这一未满足的需求,使用酒精自我给予的非人类灵长类动物模型系统进行血浆蛋白生物标志物的发现和验证,以开发一种能够准确将受试者分类为不饮酒、非滥用饮酒和滥用饮酒类别的诊断方法。
确定了一个包含 17 种血浆蛋白的面板,该面板具有 100%的灵敏度,可以正确地将滥用饮酒分类,并且还可以以 88%的准确率将任何饮酒水平与酒精戒断区分开来。
该生物标志物面板反映了多个器官系统的变化,并提示与饮酒相关的血浆蛋白质组发生了强烈变化,这可能成为一种敏感和特异性的诊断测试。与酒精自我给予相关的特定血浆蛋白的改变可能代表了各种器官系统中与酒精诱导的应激相关的指标。